rs41281310

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_022124.6(CDH23):​c.3293A>G​(p.Asn1098Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00414 in 1,613,678 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). The gene CDH23 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.0025 ( 2 hom., cov: 33)
Exomes 𝑓: 0.0043 ( 25 hom. )

Consequence

CDH23
NM_022124.6 missense

Scores

3
7
7

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 9.29

Publications

8 publications found
Variant links:
Genes affected
CDH23 (HGNC:13733): (cadherin related 23) This gene is a member of the cadherin superfamily, whose genes encode calcium dependent cell-cell adhesion glycoproteins. The encoded protein is thought to be involved in stereocilia organization and hair bundle formation. The gene is located in a region containing the human deafness loci DFNB12 and USH1D. Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of this cadherin-like gene. Upregulation of this gene may also be associated with breast cancer. Alternative splice variants encoding different isoforms have been described. [provided by RefSeq, May 2013]
C10orf105 (HGNC:20304): (chromosome 10 open reading frame 105) Predicted to be integral component of membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_022124.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.01566711).
BP6
Variant 10-71712737-A-G is Benign according to our data. Variant chr10-71712737-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 45913.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00246 (375/152362) while in subpopulation NFE AF = 0.004 (272/68040). AF 95% confidence interval is 0.00361. There are 2 homozygotes in GnomAd4. There are 162 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,Unknown gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022124.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH23
NM_022124.6
MANE Select
c.3293A>Gp.Asn1098Ser
missense
Exon 28 of 70NP_071407.4
C10orf105
NM_001164375.3
MANE Select
c.*3199T>C
3_prime_UTR
Exon 2 of 2NP_001157847.1Q8TEF2
CDH23
NM_001171930.2
c.3293A>Gp.Asn1098Ser
missense
Exon 28 of 32NP_001165401.1A0A087WYR8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDH23
ENST00000224721.12
TSL:5 MANE Select
c.3293A>Gp.Asn1098Ser
missense
Exon 28 of 70ENSP00000224721.9Q9H251-1
C10orf105
ENST00000441508.4
TSL:1 MANE Select
c.*3199T>C
3_prime_UTR
Exon 2 of 2ENSP00000403151.2Q8TEF2
CDH23
ENST00000616684.4
TSL:5
c.3293A>Gp.Asn1098Ser
missense
Exon 28 of 32ENSP00000482036.2A0A087WYR8

Frequencies

GnomAD3 genomes
AF:
0.00246
AC:
375
AN:
152244
Hom.:
2
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00104
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00255
Gnomad ASJ
AF:
0.00259
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000413
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00400
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00227
AC:
563
AN:
247856
AF XY:
0.00234
show subpopulations
Gnomad AFR exome
AF:
0.000975
Gnomad AMR exome
AF:
0.00122
Gnomad ASJ exome
AF:
0.00240
Gnomad EAS exome
AF:
0.0000557
Gnomad FIN exome
AF:
0.000558
Gnomad NFE exome
AF:
0.00390
Gnomad OTH exome
AF:
0.00266
GnomAD4 exome
AF:
0.00432
AC:
6307
AN:
1461316
Hom.:
25
Cov.:
31
AF XY:
0.00413
AC XY:
3005
AN XY:
726918
show subpopulations
African (AFR)
AF:
0.000807
AC:
27
AN:
33478
American (AMR)
AF:
0.00152
AC:
68
AN:
44710
Ashkenazi Jewish (ASJ)
AF:
0.00298
AC:
78
AN:
26134
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.000499
AC:
43
AN:
86218
European-Finnish (FIN)
AF:
0.000640
AC:
34
AN:
53146
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5766
European-Non Finnish (NFE)
AF:
0.00530
AC:
5896
AN:
1111810
Other (OTH)
AF:
0.00262
AC:
158
AN:
60356
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.484
Heterozygous variant carriers
0
340
680
1019
1359
1699
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
242
484
726
968
1210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00246
AC:
375
AN:
152362
Hom.:
2
Cov.:
33
AF XY:
0.00217
AC XY:
162
AN XY:
74516
show subpopulations
African (AFR)
AF:
0.00103
AC:
43
AN:
41580
American (AMR)
AF:
0.00255
AC:
39
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00259
AC:
9
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4834
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00400
AC:
272
AN:
68040
Other (OTH)
AF:
0.00142
AC:
3
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
20
41
61
82
102
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00341
Hom.:
3
Bravo
AF:
0.00276
EpiCase
AF:
0.00403
EpiControl
AF:
0.00439

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not provided (6)
-
-
2
not specified (2)
-
-
1
CDH23-related disorder (1)
-
-
1
Retinitis pigmentosa-deafness syndrome (1)
-
-
1
Usher syndrome type 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.26
T
BayesDel_noAF
Benign
-0.13
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Benign
0.21
T
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.36
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.96
D
M_CAP
Pathogenic
0.35
D
MetaRNN
Benign
0.016
T
MetaSVM
Benign
-0.36
T
MutationAssessor
Pathogenic
2.9
M
PhyloP100
9.3
PrimateAI
Uncertain
0.49
T
REVEL
Uncertain
0.51
Sift4G
Pathogenic
0.0
D
Varity_R
0.30
gMVP
0.67
Mutation Taster
=33/67
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs41281310;
hg19: chr10-73472494;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.